UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group

Pediatric blood & cancer, 2015-04, Vol.62 (4), p.629-636

2015

Volltextzugriff (PDF)

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

The New England journal of medicine, 2014-10, Vol.371 (16), p.1507-1517

2014

Volltextzugriff (PDF)

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia

The lancet oncology, 2008-09, Vol.9 (9), p.873-883

2008

Volltextzugriff (PDF)

47 Attention and Working Memory (WM) in Pediatric Patients Prior to Hemopoietic Stem Cell Transplant (HSCT) for Hematologic Malignancies

Journal of the International Neuropsychological Society, 2023-11, Vol.29 (s1), p.653-654

2023

Volltextzugriff (PDF)

Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia

JAMA pediatrics, 2022-02, Vol.176 (2), p.176

2022

Volltextzugriff (PDF)

Unrelated Donor Bone Marrow Transplantation for Children With Acute Myeloid Leukemia Beyond First Remission or Refractory to Chemotherapy

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4326-4332

2008

Volltextzugriff (PDF)

KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial

Blood, 2022-12, Vol.140 (24), p.2556-2572

2022

Volltextzugriff (PDF)

Nutritional risk factors predict severe acute graft‐versus‐host disease and early mortality in pediatric allogeneic hematopoietic stem cell transplantation

Pediatric blood & cancer, 2018-02, Vol.65 (2), p.n/a

2018

Volltextzugriff (PDF)

Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD

Journal of clinical immunology, 2022-01, Vol.42 (1), p.36-45

2022

Volltextzugriff (PDF)

Outcomes of matched sibling donor bone marrow transplantation in children using single‐agent calcineurin inhibitors as prophylaxis for graft versus host disease

Pediatric blood & cancer, 2018-01, Vol.65 (1), p.n/a

2018

Volltextzugriff (PDF)

Pilot experience with opebacan/rBPI21 in myeloablative hematopoietic cell transplantation

F1000 research, 2015, Vol.4, p.1480

2015

Volltextzugriff (PDF)

Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients

Transplantation and cellular therapy, 2021-02, Vol.27 (2), p.169.e1-169.e9

2021

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation in adolescent patients with chronic granulomatous disease

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-03, Vol.7 (3), p.1052-1054.e2

2019

Volltextzugriff (PDF)

784 SINGLE CENTER RETROSPECTIVE ANALYSIS OF HEMATOPOIETIC STEM CELL TRANSPLANT IN PATIENTS WITH MONOGENIC INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-171-S-171

2023

Volltextzugriff (PDF)

Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

Journal of allergy and clinical immunology, 2023-04, Vol.151 (4), p.1081-1095

2023

Volltextzugriff (PDF)

Updated Efficacy and Safety of Tabelecleucel in Patients with Epstein-Barr Virus-Positive (EBV+) Leiomyosarcomas (LMS)

Blood, 2022-11, Vol.140 (Supplement 1), p.7524-7526

2022

Volltextzugriff (PDF)

CD3+/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders

Biology of blood and marrow transplantation, 2019-03, Vol.25 (3), p.549-555

2019

Volltextzugriff (PDF)

Partially CD3+-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.493-501

2020

Volltextzugriff (PDF)

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Blood, 2023-12, Vol.142 (24), p.2105

2023

Volltextzugriff (PDF)

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

Journal of clinical immunology, 2021-01, Vol.41 (1), p.38-50

2021

Volltextzugriff (PDF)

Single-Agent Calcineurin-Inhibitor (CNI) for the Prevention of Graft Versus Host Disease (GVHD) in Pediatric Patients Undergoing HLA-Identical Sibling Bone Marrow Transplant (BMT)

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S366-S366

2017

Volltextzugriff (PDF)

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.947-952

2013

Volltextzugriff (PDF)

OR37 Persistence of T cells from the first donor after a second allogeneic stem cell transplantation

Human immunology, 2017-09, Vol.78, p.33-33

2017

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(139)

Publikationsform

Artikel
(145)
Bücher
(1)

Sprache

Englisch
(146)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(70)
Science & Technology
(70)
Humans
(68)
Child
(48)
Female
(48)
Male
(47)
Child, Preschool
(41)
Adolescent
(40)
Biological And Medical Sciences
(38)
Medical Sciences
(35)
Hematology
(34)
Infant
(32)
Pediatrics
(32)
Oncology
(27)
Adult
(20)
Immunology
(20)
Hematologic And Hematopoietic Diseases
(18)
Stem Cell Transplantation
(18)
Transplantation
(17)
Bone Marrow Transplantation
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia

47 Attention and Working Memory (WM) in Pediatric Patients Prior to Hemopoietic Stem Cell Transplant (HSCT) for Hematologic Malignancies

Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia

Unrelated Donor Bone Marrow Transplantation for Children With Acute Myeloid Leukemia Beyond First Remission or Refractory to Chemotherapy

KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

Nutritional risk factors predict severe acute graft‐versus‐host disease and early mortality in pediatric allogeneic hematopoietic stem cell transplantation

Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD

Outcomes of matched sibling donor bone marrow transplantation in children using single‐agent calcineurin inhibitors as prophylaxis for graft versus host disease

Pilot experience with opebacan/rBPI21 in myeloablative hematopoietic cell transplantation

Effect of Rabbit ATG PK on Outcomes after TCR-αβ/CD19-depleted Pediatric Haploidentical HCT for Hematologic Malignancy

Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients

Allogeneic hematopoietic stem cell transplantation in adolescent patients with chronic granulomatous disease

784 SINGLE CENTER RETROSPECTIVE ANALYSIS OF HEMATOPOIETIC STEM CELL TRANSPLANT IN PATIENTS WITH MONOGENIC INFLAMMATORY BOWEL DISEASE

Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

Updated Efficacy and Safety of Tabelecleucel in Patients with Epstein-Barr Virus-Positive (EBV+) Leiomyosarcomas (LMS)

CD3+/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders

Partially CD3+-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

Single-Agent Calcineurin-Inhibitor (CNI) for the Prevention of Graft Versus Host Disease (GVHD) in Pediatric Patients Undergoing HLA-Identical Sibling Bone Marrow Transplant (BMT)

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1

OR37 Persistence of T cells from the first donor after a second allogeneic stem cell transplantation

Suchergebnisse filtern